How many clients with refractory psychosis are eligible for both cognitive-behaviour therapy and clozapine? A chart-review study
Substantial evidence supports the use of either clozapine or cognitive-behaviour therapy (CBT) for refractory symptoms of psychosis, and are recommended in many national guidelines. However, the two treatments have not been directly compared in a head-to-head trial. The aim of this study is to estim...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2019-01-01
|
| Series: | Cogent Psychology |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/23311908.2019.1611208 |